NeuroPace, Inc. (NPCE) financial statements and ratios from SEC XBRL: revenue $99.99M (TTM), net margin -21.5%, revenue growth 25.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $99.99M |
| Net Margin | -21.5% |
| Revenue Growth (YoY) | 25.1% |
| EPS Growth (YoY) | -29.0% |
| FCF Growth (YoY) | -37.9% |
| Price / Book | 40.50 |
| Price / Sales | 5.10 |
| FCF Yield | -7.0% |
| Altman Z-Score | -2.75 (distress) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
NPCE overview · NPCE earnings · NPCE KPIs · NPCE investor relations · NPCE ownership · NPCE peers · NPCE filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.